Clinical trial

Disclosing Dementia Risk Based on Plasma Phosphorylated Tau

NCT05377060

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-09-01

PhaseNA

Study timeline

Study start (actual)2022-09-01Date precision: day

Registry last updated2025-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Mild Cognitive Impairmentunresolved

Interventions

Plasma p-tau risk disclosureBEHAVIORAL

Standard risk disclosureBEHAVIORAL

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05377060 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.